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ABSTRACT
Mechanical loading is a potent stimulus of bone adaptation, requiring
the replenishment of the osteoblast from a progenitor population. One
such progenitor is themesenchymal stem cell (MSC), which undergoes
osteogenic differentiation in response to oscillatory fluid shear. Yet, the
mechanism mediating stem cell mechanotransduction, and thus the
potential to target this therapeutically, is poorly understood. In this study,
we demonstrate that MSCs utilise cAMP as a second messenger in
mechanotransduction, which is required for flow-mediated increases in
osteogenic gene expression. Furthermore, we demonstrate that this
mechanosignalling is dependent on the primary cilium and the ciliary
localised adenylyl cyclase 6. Finally, we also demonstrate that this
mechanotransduction mechanism can be targeted therapeutically to
enhance cAMP signalling and early osteogenic signalling, mimicking
the beneficial effect of physical loading. Our findings therefore
demonstrate a novel mechanism of MSC mechanotransduction
that can be targeted therapeutically, demonstrating a potential
mechanotherapeutic for bone-loss diseases such as osteoporosis.
This article has an associated First Person interviewwith the first author
of the paper.
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INTRODUCTION
Bone has long been established as a mechanosensitive organ that
can adapt its structure to meet the demands of its mechanical
environment, maintaining an optimal strength-to-weight ratio
(Robling et al., 2007; Robling and Turner, 2002; Frost, 1963).
This mechanically driven adaptation requires a continued
replenishment of bone-forming osteoblasts, achieved through the
differentiation of mesenchymal stem cells (MSCs) (Knight and
Hankenson, 2013). This loading-induced MSC osteogenic lineage
commitment is thought to occur in part via direct mechanosensing
of physical stimuli, leading to MSC osteogenic differentiation and
bone formation (Govey et al., 2013; Hoey et al., 2012b; Curtis et al.,
2018). Loading-induced deformation of bone creates a complex
mechanical microenvironment within the stem cell niche consisting
of strain, pressure and fluid flow (Gurkan and Akkus, 2008). A large
body of work has demonstrated that physiological oscillatory
fluid shear (OFS) is a potent regulator of bone homeostasis,
triggering an osteogenic response in osteoblasts, osteocytes and
stem cells (Yourek et al., 2010; Thompson et al., 2012). In particular,
a systematic study investigating the effect of OFS on MSCs
demonstrated that OFS triggers an increase in cyclo-oxygenase 2
(Cox2, also known as PTGS2), osteopontin (Opn, also known as
SPP1) and runt-related transcription factor 2 (Runx2) expression
at early time points (1, 2 and 4 hrs) that resulted in enhanced collagen
andmineral deposition over 21 days (Stavenschi et al., 2017). Despite
the known contribution of mechanical loading to MSC osteogenic
differentiation and bone formation, the mechanism by which these
cells transduce mechanical stimuli into cellular activity,
mechanotransduction, remains poorly understood. Deciphering
these mechanisms would greatly aid in the development of
mechanotherapies to prevent bone loss and promote regeneration in
skeletal diseases such as osteoporosis (Rando and Ambrosio, 2018).
Second messengers are one of the initiating biochemical
components of intracellular signalling cascades triggered by a
biophysical stimulus. Intracellular calcium (Ca2+) has been the
predominant second messenger studied in response to fluid shear,
where rapid fluxes in intracellular Ca2+ following OFS result in
downstream transcriptional activity in bone cells (Hung et al., 1995;
Lewis et al., 2017; Lyons et al., 2017). Moreover, human MSCs have
demonstrated intracellular Ca2+ increases following fluid shear that
are required for downstream osteogenic gene expression (Liu et al.,
2015; Corrigan et al., 2018). Alternatively, cyclic adenosine 3′,5′-
monophosphate (cAMP) is another second messenger activated in
response to fluid shear but its role in the osteogenic lineage is less well
studied (Kamenetsky et al., 2006). Fluid shear has been shown to
induce an increase in cAMP production in a time- and magnitude-
dependent manner in rat calvarial osteoblasts (Reich et al., 1990),
indicating that cAMP is mechanoresponsive in bone cells. Moreover,
cAMP signalling is biphasic in osteocytes undergoing an initial
decrease followed by an increase after 30 min of OFS (Kwon et al.,
2010). A recent study in humanMSCs demonstrated that activation of
cAMP signalling augmented MSC osteogenesis in an ectopic bone
formation model in immune-deficient mice (Siddappa et al., 2008),
indicating that MSCs may too utilise cAMP as a potential pre-
osteogenic signal; however, the role of cAMP as a second messenger
in MSC mechanotransduction is poorly understood.
cAMP is universally generated by adenylyl cyclases, a family of
enzymes that catalyse the cyclisation of adenosine triphosphate (ATP)Received 16 July 2018; Accepted 21 September 2018
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into cAMP (Kamenetsky et al., 2006). The adenylyl cyclase family
comprises nine distinct transmembrane isoforms (AC1–AC9, also
known as ADCY1–ADCY9), where each of the transmembrane
adenylyl cyclases have individual regulatory properties, and the nine
subtypes are expressed in only a limited number of tissues (Hanoune
and Defer, 2001; Defer et al., 2000). Specifically, adenylyl cyclase 6
(AC6, also known as ADCY6) has been shown to be expressed in
mature bone cells and is required for loading-induced bone formation
in vivo (Lee et al., 2014). Interestingly, skeletally mature mice with
a global deletion of AC6 did not present with a skeletal phenotype
but formed significantly less bone than control mice following
ulnar loading, demonstrating that AC6 is involved specifically in
mechanotransduction leading to functional bone mechanoadaptation
(Lee et al., 2014). Additional in vitro studies have demonstrated a role
for AC6 in osteocyte mechanotransduction (Kwon et al., 2010), but
the potential role of AC6 in MSCs remains unknown.
Primary cilia are solitary, immotile microtubule-based organelles
that protrude from the membrane in various cell types, including bone
(Hoey et al., 2012a), and have recently emerged as a nexus of intra- and
extracellular signalling (Singla and Reiter, 2006; Lee et al., 2015).
Extending into the extracellular milieu, the primary cilium is ideally
positioned to relay both biochemical [HH (Singla and Reiter, 2006),
TGFβ (Clement et al., 2013; Labour et al., 2016) and BMP (Monnich
et al., 2018)] and biophysical [fluid shear (Hoey et al., 2012b),
compression (Wann et al., 2012) and pressure (Luo et al., 2014)] cues
and are required to maintain tissue homeostasis, with defects in the
cilium leading to a number of diseases known as ciliopathies
(Hildebrandt et al., 2011). Specifically, in bone, the depletion of
primary cilia in mature bone cells or their progenitors results in an
inhibition of the osteogenic response to fluid shear (Malone et al.,
2007; Hoey et al., 2011, 2012b), with these findings verified using in
vivo models (Temiyasathit et al., 2012; Chen et al., 2016),
demonstrating the important role of the cilium in bone and stem cell
mechanobiology. To identify new anabolic therapeutics, recent efforts
have attempted to decipher themolecular mechanism of cilia-mediated
mechanotransduction with contrasting results. Cilia-mediated
mechanotransduction is predominately believed to be propagated by
Ca2+ signalling with initial studies by Praetorius and Spring (2001)
being verified by advanced cilia-localised genetically encoded Ca2+
indicators (Jin et al., 2014; Lee et al., 2015). Interestingly, work has
recently emerged suggesting that primary cilia are not Ca2+-responsive
mechanosensors, as previously thought (Delling et al., 2016).
Although these discrepancies may be associated with differences in
the Ca2+ sensors utilised, it has raised the possibility of an alternative
second messenger in cilia mechanotransduction, namely cAMP.
Previous work has demonstrated that ciliary cAMP levels are fivefold
higher than cytosolic cAMP in mouse embryonic fibroblasts and
murine inner medullary collecting duct cells (IMCD3), and that this
compartmentalised cAMP is regulated by adenylyl cyclases that
localise to the ciliary microdomain (Moore et al., 2016). Moreover,
AC6 was shown to localise to the primary cilium of cholangiocytes
and osteocytes and was required for fluid shear-induced cAMP
signalling (Masyuk et al., 2006; Mick et al., 2015; Kwon et al., 2010),
indicating that cilium may also be a cAMP-responsive mechanosensor
and that molecular mechanisms may be cell type-dependent.
However, despite the progress in research into cilia-mediated
mechanotransduction in mature bone cells, its mechanism in stem
cells remains unknown.
Therefore, the aim of this study was to determine the molecular
mechanism of cilia-mediated mechanotransduction in MSCs, which
would facilitate the development of novel mechanotherapies to
promote early osteogenic signalling in these cells. Here, with the use
of custom-built bioreactors, we demonstrate that MSCs utilised
cAMP signalling as a second messenger in mechanotransduction,
and that this cAMP response is dependent on the primary cilium and
the localisation of AC6 to this organelle. Moreover, we demonstrate
mechanotherapeutic potential by biochemically targeting cAMP
signalling, mimicking the beneficial effect of physical loading, which
demonstrates a potential novel anabolic treatment to enhance MSC
osteogenesis.
RESULTS
MSCs utilised cAMP signalling as a second messenger
in mechanotransduction
To determine whether MSCs utilise cAMP signalling as a second
messenger in fluid shear mechanotransduction, we quantified cAMP
levels immediately following exposure for 2, 15 and 30 min of OFS.
We found that in cells subjected to 15 min of OFS, cellular cAMP
levels significantly increased by 2.9-fold compared to no-flow
controls (P<0.05; Fig. 1A), indicating cAMP as a second messenger
inMSCmechanotransduction. This responsewas temporal, in that no
changes were seen following 2 min of OFS and returned to basal
levels after 30 min ofOFS (Fig. 1A), demonstrating similar profiles to
that seen with Ca2+ signalling. As no change was seen following
either 2 or 30 min of OFS, our remaining experiments focused on
investigating the mechanisms involved in flow-induced increases of
cAMP after 15 min of OFS.
As cAMP signalling is predominately regulated via adenylyl
cyclases, we utilised a general adenylyl cyclase inhibitor,
MDL-12,330A hydrochloride (MDL), to investigate whether this
OFS-induced increase in cAMP was adenylyl cyclase-dependent.
Firstly, we performed a dose response study for 15 min to determine
the optimum concentration of MDL that would inhibit adenylyl
cyclase activity, but that did not affect basal cAMP levels. MDL at
concentrations of 100 and 200 µM resulted in significant decreases
in basal cAMP levels (Fig. 1B). A concentration of 10 µM was
chosen as it was the lowest concentration of MDL and did not elicit
any significant changes in cAMP levels (Fig. 1B). We found that
treating MSCs with 10 µM MDL blocked the OFS-induced
increases in cAMP (P<0.05; Fig. 1C), demonstrating that the
OFS-mediated cAMP response was dependent on adenylyl cyclase
activity. Thereafter, to investigate whether cAMP second messenger
signalling is required for fluid shear-induced MSC osteogenesis,
adenylyl cyclase activity was inhibited as above and osteogenic
gene expression was analysed following 2 h of OFS. We found that
MSCs displayed a positive early osteogenic response when
subjected to a regime that has previously been shown to elicit
osteogenic responses after 2 h of OFS at 1 Pa, 1 Hz (Stavenschi
et al., 2017), where there was a significant increase in the expression
of the osteogenic genes Cox2 and Opn (P<0.05) and approached
significance in Runx2 (P=0.072) when compared to static no-flow
conditions (Fig. 1D–F). However, when we blocked cAMP
signalling with MDL treatment, this significant increase was lost
in all genes analysed (Fig. 1D–F), demonstrating that MSCs utilise
cAMP as a second messenger in loading-induced osteogenesis.
MSCs express seven of the nine transmembrane adenylyl
cyclase isoforms, including AC6
Adenylyl cyclases are GTP-dependent enzymes that are responsible
for the conversion of ATP to cAMP (Hanoune and Defer, 2001).
Nine membrane-bound isoforms have been identified, with seven of
these, AC2–AC7 and AC9, expressed in mature bone cells (Kwon
et al., 2010). To determine what adenylyl cyclase isoforms are
expressed in progenitor cells, utilising quantitative real-time PCR
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(qRT-PCR), we found that there are also seven isoforms present in
MSCs, but interestingly, the expression pattern is different to that
seen in osteocytes. Here, we found that the genes Ac1, Ac3, Ac4 and
Ac6–Ac9 are expressed, whereas Ac2 and Ac5 were not detected
(Fig. 2A). Interestingly, of the seven isoforms present, Ac6 was
one of the more abundantly expressed and has previously be
shown to be critical for loading-induced bone formation (Lee et al.,
2014). To investigate AC6 further, we examined AC6 protein
expression and spatial organisation using immunocytochemistry
and found that AC6 is expressed across the MSC cell membrane
(Fig. 2B). No staining was found when AC6 primary antibody was
withheld (Fig. S1).
Adenylyl cyclase 6 is required for fluid shear-induced cAMP
signalling in MSCs
To investigate the role of AC6 in flow-mediated changes in cAMP
signalling, we depleted AC6 in MSCs using small-interfering RNA
(siRNA). Ac6 gene expression levels, as quantified by qRT-PCR,
Fig. 1. MSCs utilise cAMP signalling as a secondmessenger duringmechanotransduction. (A) Effect of oscillatory fluid flow over MSCs at 1 Pa, 1 Hz for 2,
15 and 30 min on cAMP concentration (N=3, n=6). (B) Dose-response test of the adenylyl cyclase inhibitor MDL on cAMP concentration in MSCs (N=3,
n=6). (C) Effect of 10 µMMDL on cAMP concentration following oscillatory fluid flow at 1 Pa, 1 Hz for 15 min (N=3, n=9). (D–F) Effect of MDL on Cox2 (D), Runx2
(E) and Opn (F) gene expression following oscillatory fluid flow at 1 Pa, 1 Hz for two hours (N=2, n=6), compared to no-flow vehicle control. Statistical tests:
unpaired two-tailed Student’s t-test with Wilcoxon correction (A), one-way ANVOAwith Bonferroni post-test (B), and two-way ANOVAwith Bonferroni post-tests
(C–F). Values are means±s.e.m. for three independent replicates. *P<0.05, **P<0.01, ***P<0.001; NS, not significant.
Fig. 2. MSCs express seven of the
nine transmembrane adenylyl
cyclase isoforms, including AC6.
(A) Mean±s.e.m. relative gene
expression of adenylyl cyclases Ac1–
Ac9 in MSCs, quantified by qRT-PCR.
Ac3, Ac6, Ac7 and Ac9 show the
highest expression of the nine adenylyl
cyclases analysed. Ac2 and Ac5 were
not detected (n=3). (B) Verification of
AC6 protein expression in MSC with
the use of immunocytochemistry. Cells
were stained for AC6 (green) and
nuclei counterstained with DAPI (blue).
Scale bar: 20 µm. ND, not detected.
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were 75% lower in MSCs treated with Ac6 siRNA when compared
to scrambled siRNA controls (P<0.001; Fig. 3A). MSCs treated
with either off-target scrambled or Ac6 siRNA were subjected to
15 min of OFS to assess the role of AC6 in OFS activation of cAMP
signalling. When exposed to flow, MSCs treated with scrambled
siRNA exhibited a 2.6-fold increase in cAMP signalling (P<0.05;
Fig. 3B), demonstrating no effect of the transfection treatment.
However, upon depletion of AC6 no change in cAMP activity was
found in MSCs following shear (Fig. 3B), demonstrating the
specific role of AC6 in regulating mechanically activated cAMP
signalling.
AC6 is required for fluid shear-induced osteogenic gene
expression in MSCs
Given the demonstrated role of AC6 in fluid shear-induced increases
in cAMP signalling, we next investigated whether AC6 also plays a
role in downstream osteogenesis. MSCs treated with either
scrambled or Ac6 siRNA as above were subjected to OFS at 1 Pa,
1 Hz as previously described (Stavenschi et al., 2017). Expression
of Cox2, Runx2 and Opn in the no flow control group were
unaffected by the Ac6 siRNA treatment, demonstrating that AC6
activity does not significantly influence basal osteogenic gene
expression (Fig. 4). Furthermore, analysis of osteogenic gene
expression in MSCs treated with scrambled siRNA and exposed to
flow, resulted in significant 4-, 3.16- and 3.60-fold increases in
Cox2, Runx2 and Opn mRNA levels, respectively, compared to
scrambled siRNA no-flow controls (P<0.05; Fig. 4). However,
similar to that seen with cAMP signalling, depletion of AC6 resulted
in a complete loss of the fluid shear-induced increases in osteogenic
gene expression (Fig. 4), demonstrating that AC6 is a critical
component of MSC mechanotransduction through regulation of
cAMP second messenger signalling.
AC6 is localised to the microdomain of the primary cilium in
MSCs
Given the previously demonstrated role of the primary cilium in
MSC mechanotransduction and spatial organisation of adenylyl
cyclases at the primary cilium in other cell types, we next examined
whether AC6, responsible for the flow-mediated changes in cAMP
and gene expression, is localised to the primary cilium in MSCs.
Utilising immunocytochemistry, MSCs were co-immunostained for
AC6 and acetylated α-tubulin, which is enriched within the primary
cilium. Primary cilia were identified in the perinuclear region of the
cell, extending as rod-like structures on the apical surface. As
previously demonstrated (Kwon et al., 2010), AC6 was found
throughout the cell membrane but upon co-staining for acetylated α-
tubulin, a distinct spatial organisation was revealed within the
primary cilium, with intense staining found along the ciliary
Fig. 3. AC6 is required for fluid shear-induced cAMP signalling in MSCs. (A) Ac6 expression was successfully knocked down in MSCs using siRNA
technology, as verified by qRT-PCR, normalised toActβ expression and compared to scrambled siRNA control (N=3, n=13). (B) Effect of oscillatory fluid flow over
MSCs treated with scrambled andAc6 siRNA at 1 Pa, 1 Hz for 15 min on cAMP concentration (N=3, n=9), compared to scrambled no-flow control. Statistical tests:
unpaired two-tailed Student’s t-test (A) and two-way ANOVA with Bonferroni post-test (B). Values are means±s.e.m. for a minimum of three independent
replicates. *P<0.05, ***P<0.001.
Fig. 4. Adenylyl cyclase 6 is required for fluid shear-induced osteogenic gene expression in MSCs. (A–C) Effect of oscillatory fluid flow at 1 Pa, 1 Hz on
expression of osteogenic genes Cox2 (A), Runx2 (B) and Opn (C) after 2 h (N=4, n=9–12), as determined by qRT-PCR. All groups are compared to no-flow
scrambled control. Statistical test: two-way ANOVAwith Bonferroni post-hoc. Values are means±s.e.m. for a minimum of three independent replicates. *P<0.05,
***P<0.001.
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microdomain (Fig. 5). This therefore indicates that cilia-mediated
MSC mechanotransduction may be dependent on AC6 and its
regulation of cAMP signalling. No staining was detected when AC6
primary antibody was withheld (Fig. S2).
Primary cilium-mediated mechanotransduction in MSCs is
cAMP dependent
The primary cilium has previously been shown to be required for
stem cell mechanotransduction, specifically with regards to fluid
shear-induced increases in osteogenic gene expression (Hoey et al.,
2012b). Therefore, given the localisation of AC6 to the primary
cilium compartment and the demonstrated role of cAMP in MSC
mechanotransduction, the role of the primary cilium in fluid shear-
induced cAMP signalling was then investigated. The formation of
cilia was inhibited through the utilisation of siRNA targeting Ift88,
which is a principal motor protein required for ciliogenesis. The
transfection resulted in significantly diminished Ift88 mRNA
expression, which in turn significantly reduced the incidence of
primary cilia by 74% as demonstrated by immunocytochemistry
(P<0.05; Fig. 6A–D). MSCs transfected with siRNA targeting
Ift88 or scrambled siRNA were subjected to OFS, and cAMP
signalling was analysed as above. The scrambled siRNA treatment
did not affect basal or fluid shear-induced increases in cAMP in
MSCs following fluid shear (3.74-fold, P<0.05; Fig. 6E). However,
upon inhibition of primary cilia, the fluid shear-induced increase in
cAMP was lost (Fig. 6E), mirroring that with AC6 depletion. This
therefore demonstrates that the cilium is a cAMP-responsive
mechanosensor in MSCs, which potentially utilises AC6 to
mediate this second messenger and downstream osteogenic
response, demonstrating a novel molecular mechanism of cilia-
mediated mechanotransduction in MSCs.
cAMP signalling can be biochemically activated with an
adenylyl cyclase activator, demonstrating artificial
mechanotransduction and mechanotherapeutic potential
Next, we wanted to investigate whether the biochemical activation
of this novel MSC mechanotransduction mechanism via adenylyl
cyclases could mimic the observed cAMP signalling responses
to OFS. A dose-response study was carried out to determine
whether the adenylyl cyclase activator, forskolin (FSK), could
biochemically mimic the effects of OFS on cAMP signalling. We
found that 15 min of treatment with 0.01 mM and 0.001 mM of
FSK induced 25- and 12-fold increases in cAMP levels, respectively
(P<0.001; Fig. 7A), which were considerably larger increases than
that seen following OFS. However, cAMP levels increased 2.5-fold
compared to the vehicle control in cells treated with 0.1 µM FSK
(P<0.05; Fig. 7B). As the aim of this study was to biochemically
induce similar increases in cAMP to those seen with fluid shear,
cells were treated with 0.1 µM FSK for further studies. Importantly,
0.1 µM FSK treatment was not only able to mimic cAMP signalling
following OFS, but also that of the osteogenic response, where
treatment with 0.1 µM FSK resulted in significant increases in
Cox2, Runx2 and Opn expression (P<0.05; Fig. 7C–E), to a similar
degree to that seen with fluid shear. This result demonstrated
artificial mechanotransduction and highlighted FSK as a potential
anabolic mechanotherapeutic to enhance MSC osteogenesis.
Moreover, given the demonstrated role of AC6 in fluid shear-
induced increases in cAMP signalling and osteogenic gene
expression, we next investigated whether AC6 also plays a role in
FSK-induced increases in osteogenesis. MSCs treated with either
scrambled or Ac6 siRNA, as above, were subjected to 0.1 µM FSK
treatment as previously described. The expression of Cox2 and Opn
in the vehicle control group showed a trend towards an increase in
expression; however, this was not significant (P>0.05; Fig. 7F–H).
Furthermore, analysis of osteogenic gene expression in MSCs
treated with scrambled siRNA and exposed to FSK resulted in
significant 3.19-, 3.43- and 2.59-fold increases in Cox2, Runx2 and
Opn mRNA levels, respectively, compared to no-treatment controls
(P<0.05; Fig. 7F–H). However, similar to the changes seen with
cAMP signalling and OFS, depletion of AC6 resulted in a complete
loss of the increase in osteogenic gene expression following FSK
treatment (Fig. 7F–H), demonstrating that AC6 is a critical
component of MSC osteogenesis.
Primary cilia have been shown previously to be required for
fluid flow-induced increases in osteogenic gene expression (Hoey
et al., 2012b) and this study has demonstrated the role of primary
cilia in cAMP signalling. Therefore, we wanted to investigate the
role of the primary cilium in FSK-induced osteogenesis. As
previously described, the formation of cilia was inhibited with the
treatment of siRNA targeting Ift88. MSCs transfected with
siRNA targeting Ift88 or scrambled siRNA were subjected to
treatment with 0.1 µM FSK, and osteogenic gene expression was
analysed as above. The scrambled siRNA treatment did not affect
basal or FSK-induced increases in Cox2, Runx2 or Opn in MSCs
(3.14-, 3.41- and 2.59-fold, P<0.05; Fig. 7I–K). However, upon
inhibition of primary cilium formation, the FSK-induced increase
in osteogenic gene expression was lost (Fig. 7I–K), mirroring that
with AC6 depletion. This therefore demonstrates that activating
osteogenic genes via FSK treatment requires a functional cilium
in MSCs.
Fig. 5. AC6 is localised to the primary cilium in MSCs. AC6 (green) and
acetylated α-tubulin (red) co-localisation to the primary cilia (identified as linear
structures enriched in acetylated α-tubulin). Nuclei are counterstained with
DAPI (blue). N=3, n=77. Scale bar: 5 µm.
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Mechanical loading is a potent stimulus of bone adaptation, requiring
the replenishment of the osteoblast from a progenitor population. One
such progenitor is the MSC, which undergoes osteogenic
differentiation in response to OFS (Stavenschi et al., 2017). Yet, the
mechanism mediating stem cell mechanotransduction, and thus the
potential to target this therapeutically, remains poorly understood. In
this study, we demonstrate that MSCs utilise cAMP as a second
messenger in mechanotransduction, required for flow-mediated
increases in early osteogenic gene expression. Furthermore, we
show that this mechanosignalling is dependent on the primary cilium
and the ciliary localised adenylyl cyclase 6. Importantly, we also
demonstrate that this mechanotransduction mechanism can be
targeted therapeutically to enhance early osteogenic signalling in
MSCs, mimicking the beneficial effect of physical loading. Our
findings therefore demonstrate a novel mechanism of MSC
mechanotransduction that can be targeted therapeutically,
demonstrating a potential mechanotherapeutic for bone loss diseases
such as osteoporosis.
MSCs utilise cAMP as a second messenger to transduce a
biophysical stimulus into a biochemical osteogenic response. By
mimicking the marrow mechanical environment via application of
OFS, MSCs were shown to rapidly upregulate intracellular cAMP
levels 2.6-fold over static controls. This rapid increase in cAMP is in
agreement with work carried out in osteoblasts, where there was an
increase in cAMP not only over time, but also over increasing shear
magnitudes, demonstrating mechanosensitivity (Reich et al., 1990),
and demonstrates the utilisation of cAMP signalling as an important
second messenger in the skeleton. Interestingly, when this cAMP
response was inhibited, MSCs exhibited a loss of flow-induced
increases in expression of osteogenic genes, Cox2, Runx2 and Opn,
suggesting that the initial increase in cAMP is a critical component of
early loading-induced osteogenic signalling. Mechanical loading-
induced osteogenesis has previously been linked to both cAMP and
Ca2+ signalling (Thompson et al., 2012; Liu et al., 2015; Reich et al.,
1990). However, we recently demonstrated that a complete loss of
Ca2+ signalling following TRPV4 inhibition only partially blunted
the osteogenic response to fluid shear inMSC (Corrigan et al., 2018).
Given the complete loss of early osteogenic gene responses following
cAMP inhibition in this study, this may suggest a more dominant role
for cAMP signalling as a second messenger in MSC
mechanotransduction. This alternative mechanism of cAMP
signalling agrees with previous work in bone MSCs (BMSCs),
where phosphate promoted osteogenesis via a ATP-induced cAMP/
PKA pathway (Wang et al., 2016). Further to this, work in vivo has
shown that activation of the cAMP pathway results in robust increases
in bone formation in transplanted hMSCs (Siddappa et al., 2008). Our
findings therefore support a role for cyclic adenosine monophosphate
as an important messenger in MSC mechanotransduction and
osteogenesis.
Adenylyl cyclase 6 is required for OFS-induced increases in
cAMP and osteogenic gene expression. There is a growing body of
evidence detailing the expression patterns of adenylyl cyclases
within lineage-committed cells, whereas the isoforms that are
Fig. 6. Primary cilium-mediated mechanotransduction in MSCs is cAMP dependent. (A–C) Intraflagellar transport protein 88 (IFT88) expression was
knocked down in MSCs using Ift88 siRNA as verified by immunostaining (A,B) and qRT-PCR (C) (n=4). Cells were treated with either scrambled siRNA (A) or
Ift88 siRNA (B) and stained for primary cilia, identified as linear structures enriched in acetylated α-tubulin, (red; arrows) and centrioles (green; arrowhead). Nuclei
are counterstained with DAPI (blue). Scale bars: 5 μm and 1 μm (insert). (D) Effect of scrambled and Ift88 siRNA treatment on cilia incidence (N=4, n=143).
(E) Effect of oscillatory fluid flow over MSCs treated with scrambled and Ift88 siRNA at 1 Pa, 1 Hz for 15 min on cAMP concentration (N=3, n=9). Statistical tests:
unpaired two-tailed Student’s t-test with Wilcoxon correction (C,D) and two-way ANOVA with Bonferroni post-hoc (E). Values are means±s.e.m. for three
independent replicates. *P<0.05, ***P<0.001.
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Fig. 7. Cyclic AMP signalling can be biochemically activated with an adenylyl cyclase activator demonstrating artificial mechanotransduction.
(A,B) Effect of forskolin (FSK) treatment on cAMP concentration in MSCs (N=3, n=6). (C–E) Effect of forskolin treatment on expression of osteogenic
genes Cox2 (C), Runx2 (D) and Opn (E) (N=3, n=9). (F–H) AC6 is required for forskolin-induced increases in expression of osteogenic genes Cox2 (F),
Runx2 (G) and Opn (H) in MSCs after 2 h (N=2, n=6). (I–K) IFT88 is required for forskolin-induced increases in expression of osteogenic genes Cox2 (I),
Runx2 (J) and Opn (K) in MSCs after 2 h (N=2, n=6). DMSO concentration for shown is 0.01%. Statistical tests: unpaired two-tailed Student’s t-test with
Wilcoxon correction (A–E), two-way ANOVAwith Bonferroni post-hoc (F–K). Values are means±s.e.m. for three independent replicates. *P<0.05, **P<0.01,
***P<0.001.
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expressed within progenitors have not been established. Using qRT-
PCR, MSCs were found to express only seven of the nine adenylyl
cyclase isoforms, which is similar to the number seen in the
differentiated osteocyte (Kwon et al., 2010). In our study, MSCs are
shown to express Ac1, Ac3, Ac4 and Ac6–Ac9, while Ac2 and
Ac5 were not detected. This contrasts with osteocytes, which do not
express Ac1 or Ac8 (Kwon et al., 2010). These differences indicate a
preferential change in adenylyl cyclase expression with lineage
commitment. Of the four highly expressed adenylyl cyclases in
MSCs (Ac3, Ac6, Ac7 and Ac9), Ac6 has been shown to have an
important role in bone mechanoadaptation both in vitro and in vivo
(Kwon et al., 2010; Lee et al., 2014), while Ac3, Ac7 and Ac9 have
predominately been associated with the brain (Kamenetsky et al.,
2006). Therefore, we focused specifically on AC6 within this study.
Lee et al. (2014) showed that mice with a global knockout of AC6
had no skeletal phenotype abnormalities; however, they exhibited
diminished loading-induced bone formation, demonstrating a
critical role for Ac6 in skeletal mechanoadaptation. Additionally,
primary mature bone cells from these mice had an attenuated fluid
shear-induced increase in Cox2 mRNA expression compared to
controls. However, it is currently unclear if AC6 plays a role in MSC
mechanotransduction. Therefore, we further investigated the
expression pattern of AC6 specifically in MSCs through the use
of immunocytochemistry, and AC6 was found to be abundantly
expressed throughout the plasma membrane of MSCs. Knocking
downAC6 expression inMSCs did not affect basal cAMP levels but
abolished the increase in cAMP signalling in response to fluid shear,
demonstrating a similar mechanotransduction-specific role as in the
AC6 knockout animal. This trend was also evident when examining
early osteogenic signalling in MSCs, suggesting the defect in
loading-induced bone formation in vivo may be attributable to a
defect in mechanotransduction in many cell types along the
osteogenic lineage. Interestingly, the complete loss of the cAMP
and early osteogenic responses to OFS following Ac6 knock down
mirrors that seen following generic adenylyl cyclase inhibition,
indicating that AC6 is the dominant adenylyl cyclase mediating
MSC mechanotransduction. Hence, our data demonstrates a novel
role for AC6 in MSC mechanotransduction, mediating fluid shear-
induced cAMP second messenger signalling and downstream early
osteogenesis.
The primary cilium, an organelle required for fluid shear-induced
MSCosteogenesis in vitro and in vivo (Hoey et al., 2012b; Chen et al.,
2016a), localises AC6 and is required for fluid shear-induced cAMP
signalling. Recently, it has been shown that several adenylyl cyclases
localise to primary cilia in numerous cell types. Most notably, AC6 is
localised to the primary cilium in osteocytes (Kwon et al., 2010).
Furthermore, mouse embryonic fibroblasts and IMCD3s have
elevated basal ciliary cAMP levels as a result of AC5 and/or AC6
localised activity, indicating a link between AC6, cAMP and the
primary cilium (Moore et al., 2016), leading us to further investigate
the role of AC6 in the previously demonstrated primary cilia-
mediated MSC mechanotransduction. In this study, we show that
AC6 preferentially localises to the primary cilium. This specific
localisation to an area of high strain may potentially increase the
mechanosensitivity of the cell. Furthermore, due to the discrete
microdomain of the cilium and the specific localisation of a plethora
of signalling molecules, localisation of AC6 to this signalling
centre may amplify and enhance the rate of AC6-mediated
mechanosignalling. Interestingly, in MSCs which do not possess
primary cilia, fluid shear-induced increases in cAMP are lost, which
is consistent with AC6 knockdown. This therefore suggests that the
localisation of AC6 to the cilium is functionally significant and
demonstrates a potential Ca2+-independent mechanism of cilia-based
mechanotransduction (Malone et al., 2007; Delling et al., 2016). In
summary, primary cilia mediate MSC mechanotransduction via
cAMP signalling that is likely dependent on AC6 localisation to the
ciliary microdomain, demonstrating a novel molecular mechanism of
cilia-mediated MSC mechanotransduction.
Biochemical activation of adenylyl cyclases elicits a cAMP
second messenger and early osteogenic gene response that mirrors
that seen with OFS in MSCs. The adenylyl cyclase agonist
forskolin, a diterpene that stimulates cAMP production by directly
activating adenylyl cyclases (Lorenzo et al., 1986), induced a cAMP
response in MSCs similar to that elicited by OFS. Furthermore,
forskolin induced an early osteogenic response in terms of Cox2,
Runx2 and Opn expression, as seen following OFS, revealing itself
as a potential novel therapeutic that mimics the beneficial effect of
mechanical loading. This potential therapeutic role for forskolin is
consistent with previous findings where cAMP activation enhanced
bone formation of transplanted MSCs in vivo, where both 8-bromo-
cAMP and forskolin resulted in increased bone formation in pre-
treated MSCs (Doorn et al., 2012). Additionally, direct activation of
PKAwith cAMP and forskolin in rat and human osteoblast-like cell
lines led to activation of the osteocalcin promoter (Boguslawski
et al., 2000). Ablation of AC6 in MSCs was found to inhibit the
forskolin-induced increases in osteogenic gene expression, although
this was somewhat surprising as forskolin is recognised as a broad-
spectrum adenylyl cyclase agonist. Similar results have been found
in vascular smooth muscle cells (VSMCs) (Gros et al. (2006)
demonstrated that the downstream consequences of cAMP
signalling are not common to all isoforms of adenylyl cyclases in
VSMCs, with siRNA directed at Ac6 sufficient to reduce forskolin-
activated adenylyl cyclase activity. Moreover, knockdown of Ac6
alone could inhibit the forskolin-induced increases in cAMP,
synthesis and arborisation observed in control cells and cells
overexpressing AC6 (Gros et al., 2006). Our findings agree with this
study in that a knockdown of Ac6 was sufficient to inhibit the effect
of forskolin onMSC early osteogenesis. Similarly, we found that the
inhibition of primary cilia formation via siRNA targeting Ift88
blocked the forskolin-induced increases in Cox2, Runx2 and Opn
expression. This data suggests that both the primary cilium and the
ciliary localised AC6 are required for forskolin-induced alterations
in osteogenic gene expression. Together with our observations, this
demonstrates that biochemically targeting mechanotransduction
mechanisms, such as the one identified in this study, is a potential
strategy to enhance early osteogenic signalling in MSCs and bone
formation by mimicking the beneficial effects of physical loading.
In summary, this study demonstrates a novel mechanism of MSC
mechanotransduction, whereby it was shown that MSCs utilise
cAMP as an important second messenger to initiate an early
osteogenic response following fluid shear stimulation. This was
further explored, and we found that fluid shear-induced cAMP
signalling is mediated by AC6 and the primary cilium. These
findings add to the growing body of evidence detailing the
importance of ciliary-based signalling in MSCs and highlight
a Ca2+-independent mechanism of cilia-based mechanotransduction
in stem cells. This study highlights this pathway, and the various
components within, as potential targets to enhance early osteogenic
signalling in MSCs and potential bone formation. Importantly,
we have demonstrated proof-of-concept whereby forskolin
activated this novel mechanism, eliciting a cAMP and early
osteogenic response mirroring that seen with OFS, demonstrating
mechanotherapeutic potential and a new anabolic treatment for bone
loss diseases such as osteoporosis.
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Mesenchymal stem cell culture
The murine MSC line C3H10T1/2 was obtained from ATCC (LGC
Standards, Teddington, Middlesex, UK). MSCs were tested to confirm lack
of mycoplasma contamination with aMycoAlert PLUS detection kit (LT07,
Brennan & Co., Dublin, Ireland). MSCs were maintained in Dulbecco’s
modified Eagle’s medium (DMEM; D6046, Sigma-Aldrich) with low
glucose (Sigma-Aldrich, Arklow, Ireland) supplemented with 10% fetal
bovine serum (FBS; South American origin, Labtech International,
Heathfield, East Sussex, UK) and 1% penicillin streptomycin (P/S;
P4333, Sigma-Aldrich).
Mechanical stimulation
Oscillatory fluid flow-induced shear stress was applied to MSCs with the
use of in-house-designed parallel plate flow chambers as described
previously (Stavenschi et al., 2017). MSCs were seeded on fibronectin-
coated (10 µg/ml) glass slides, assembled between two plates and attached
to a programmable syringe pump (New Era Pump Systems, Farmingdale,
NY, USA). Oscillatory fluid shear was applied through a 10 ml syringe (BD
Plastipak, VWR, Dublin, Ireland) at 52.5 ml/min and 1 Hz frequency,
subjecting cells to a shear stress of 1 Pa. This stimulus was applied for 2 h.
The no-flow control setup takes into account the confined environment
experienced by the cells in the chambers, consisting of glass slides prepared
in the same way and similarly remaining in the chambers for 2 h, but not
attached to the syringe pump.
Quantitative real-time polymerase chain reaction (qRT-PCR)
Immediately after treatment, TRI reagent (93289, Sigma-Aldrich) was used to
extract RNA per the manufacturer’s protocol. The concentration of RNA in
each sample was measured using a Nanodrop spectrophotometer and sample
purity was checked via 260/280 and 260/230 absorbance ratios. 400 ng of
RNA was reverse-transcribed to cDNA using the High-Capacity cDNA
Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA).
Commercially available primers for 18s, Cox2, Runx2, Opn, Ac1–Ac9 and
Ift88 were acquired for analysis of flow and forskolin-mediated osteogenic
changes and validation of knockdowns (KSPQ12012G, Sigma-Aldrich,
St Louis, MO, USA). Quantitative RT-PCR was performed using a 20 µl
reaction mix containing 10 µl SYBR Green PCR MasterMix (Invitrogen,
Paisley, UK), 0.8 µl of each primer, and 8.4 µl dH2O and sample mix. In the
case ofRunx2 andAc1–Ac9, 0.6 µl of each primerwas used. Plates were run in
an ABI 7500 Fast PCR system (Life Technologies, Carlsbad, CA, USA). The
cycle parameters were as follows: Uracil N-glycosylase (UNG) activation was
run for 2 min at 50°C, DNA polymerase activation for 10 min at 95°C, the
melt cycle was run for 15 s at 95°C and the annealing–extending cycle for
1 min at 60°C for Cox2, Runx2, Opn and Ift88, apart from 18s and Ac1–Ac9,
whichwere run at 65°C. A no-template control (NTC)was run in each 96-well
plate to confirm the absence of contamination.
For AC6 knockdown and related oscillatory fluid shear (OFS)
experiments, qRT-PCR reactions were prepared using TaqMan Universal
PCRMix (4304437, Applied Biosystems) with ROX passive dye and a pre-
designed TaqMan Gene Expression Assay (4331182, Applied Biosystems)
for amplification using the ABI 7500 real-time PCR machine (Applied
Biosystems). The relative quantity of each sample was calculated with
reference to 18s and expressed as fold change normalised to the no-flow
control group. For validation of AC6 knockdown, the relative quantity of
AC6 was calculated with reference to Actβ. All primer sequences and
concentrations are listed in Table S1.
Quantification of cAMP signalling
Cyclic AMP activity was analysed using the commercially available Cyclic
AMP XP Assay Kit (Cell Signaling Technology, Danvers, MA, USA).
Following OFS or treatment with the adenylyl cyclase inhibitor or activator,
cells were rinsed with ice-cold phosphate-buffered saline (PBS; Sigma-
Aldrich, St Louis, MO, USA) and lysed on ice with 200 μl RLT lysis buffer
containing phenylmethylsulfonyl fluoride (PMSF; 1:200; Sigma-Aldrich).
Experimental samples (50 µl) were loaded onto the anti-cAMP XP rabbit
mAb-coated plate, with 50 µl HRP-linked cAMP solution and incubated on
an orbital plate shaker for 3 h at room temperature. Wells were washed with
200 µl 1× wash buffer four times, before incubating with 100 µl 3,3′,5,5′-
tetramethylbenzidine (TMB) substrate for 30 min at room temperature.
After 30 min, 100 µl stop solution was added. Plate absorbance was read at
450 nm. All samples including the standard curve were run in triplicate.
Immunocytochemistry
MSCs were seeded on fibronectin-coated glass coverslips for 24 h before
serum starvation in DMEM low glucose, 0.5% FBS, 1% P/S for 48 h. After
fixation in neutral buffered formalin for 10 min (Sigma-Aldrich), coverslips
were permeabilised in 0.1% Triton X-100 and non-specific binding sites
were blocked using 1% w/v BSA (Sigma-Aldrich) in PBS for 2 h at room
temperature. The primary antibody targeting the primary cilium (anti-
acetylated α-tubulin, ab24610, Abcam, Cambridge, UK) was applied
overnight at 4°C, diluted 1:1500. Next, primary antibody targeting AC6
(anti-AC6, ab14781, Abcam) was applied for 1 h at room temperature at a
dilution of 1:500. AlexaFluor 594 and AlexaFluor 488 secondary antibodies
(A21203, A11008, Life Technologies) were applied in tandem for 1 h at
room temperature at 1:500. Finally, DAPI (32670, Sigma-Aldrich) was
applied for 5 min in PBS prior to sample mounting on glass slides using
Prolong gold mounting medium (P36934, Invitrogen). For cilium incidence
and length studies, the primary antibody for centrioles (anti-pericentrin,
ab4448, Abcam) was used in conjunction with acetylated α-tubulin to
clearly identify the base of the cilium, at a dilution of 1:1000. Imaging was
performed on an Olympus IX83 epifluorescent microscope with a 100 W
halogen lamp at 100× (NA 1.40 Oil) or the Leica SP7 (Leica Microsystems,
Wetzlar, Germany) scanning confocal microscope at 63× (NA 1.40 Oil).
Controls with an absence of primary antibody were used to test for non-
specific binding and background staining of the secondary antibodies.
IFT88, primary cilium and AC6 knockdown
The formation of functional primary cilia and expression of adenylyl cyclase
6 were inhibited by siRNA-mediated depletion of IFT88, an intraflagellar
transport protein (IFT) required for functional ciliogenesis, and AC6,
respectively. Lipofectamine RNAiMAX (Invitrogen) was diluted 1:135 in
OptiMEM reduced serum transfection medium (Gibco, Foster City, CA,
USA). For IFT88 knockdown this was mixed 1:1 with predesigned Stealth
RNAi targeting Ift88 (MSS211714, Invitrogen) at a dilution of 16.7 µM in
OptiMEM and incubated at room temperature for 15 min before application.
For AC6 knockdown, lipofectamine was mixed 1:1 with Silencer Select
Ambion siRNA (4390825, Bio-Sciences, Dublin, Ireland) at a dilution of
60 pmol for 5 min. 550 µl of the reaction mix was added to cells and
incubated for 8 h at 37°C, following which 10 ml DMEM (0.5% FBS, 1%
P/S) was added to the cells for 24 h. The off-target controls were Stealth
RNAi Negative Control, Medium GC (12935300, Invitrogen) and Silencer
Negative Control (AM4641, Thermo-Fisher), respectively. For IFT88
knockdown studies, additional medium was added to each transfection after
24 h. Forty-eight hours following transfection the transfected cells were
seeded for experimentation in DMEM (0.5% FBS, 1% P/S). Transfection
efficiency was verified 72 h after transfection by qRT-PCR and
immunocytochemistry as described above. The percentage of ciliated cells
was determined and cilia length analysed by epifluorescence microscopy
using an Olympus IX83 fitted with 100× objective. Cilia lengths were
measured using ImageJ freeware.
Biochemical inhibition and activation of cAMP signalling
Cyclic AMP signalling was diminished through the inhibition of adenylyl
cyclase activity using MDL-12,330A hydrochloride (MDL; M182, Sigma-
Aldrich), as previously described (Zhang et al., 2010). A dose-response
study was performed for 15 min to determine the optimum concentration of
MDL that would inhibit adenylyl cyclase activity but does not affect basal
cAMP levels. Cells were treated for 15 min to replicate OFS conditions for
cAMP. Following this, 10 µM was chosen to be the optimal dose and
therefore was used for further studies investigating the role of adenylyl
cyclase activity and cAMP signalling in MSC mechanotransduction. MSCs
were treated with MDL-supplemented medium throughout application of
the 1 Pa mechanical stimulation, and controls were incubated for the same
time with vehicle (H2O)-treated medium for both cAMP and osteogenic
gene expression studies.
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Tomodulate cyclic AMP signalling via activation of adenylyl cyclase, the
general adenylyl cyclase agonist forskolin (FSK; F3917, Sigma-Aldrich)
was utilised (Seamon et al., 1981; Doorn et al., 2012). Dose-response
studies were also carried out, where cells were treated with increasing doses
of FSK for 15 min. As with MDL treatment, cells were treated with FSK-
supplemented medium for 15 min, and controls were incubated for the same
time with vehicle (0.01% DMSO)-treated medium, for both cAMP and
osteogenic gene expression studies. Media was supplemented with 1 µM
3-isobutyl-1-methylxanthine (IBMX) for all cAMP studies.
Data analysis
The relative expression of each gene was normalised to expression of 18s
and the results expressed as mean±s.e.m. fold-change gene expression
relative to the no-flow scrambled or vehicle control group. For the OFS and
forskolin with AC6 or Ift88 knockdown studies, a two-way ANOVA
analysis was performed with Bonferroni correction post-hoc tests. Dose-
response studies for MDL and FSK were analysed using a one-way
ANOVA, with Bonferroni post-hoc tests. All other analysis was performed
using two-tailed unpaired Student’s t-test with Wilcoxon correction. All
data were analysed using GraphPad Prism 5. Only primers with PCR
efficiencies between 90% and 110%were used. In all experiments, P<0.05
was considered statistically significant. A power analysis was conducted to
determine adequate sample sizes for all experiments (G.Power 3.1.9.2,
Dusseldorf ). Technical replicates are represented as N, while biological
replicates are represented as n.
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